Adherence and knowledgement level about treatment with patients diagnosed with schizophrenia, schizotypal and delusional disorders.
Conditions
Interventions
The intervention procedure consists in carrying out clinical interviews, followed by the identification of drug-related problems and develop an individualized action plan about pharmacological treatme
behavioural
Sponsors
Universidade Federal de Sergipe
Secretaria Municipal de Saúde de São Cristóvão
Eligibility
Inclusion criteria
Inclusion criteria: Individuals over 18 years. Diagnosed with schizophrenia, schizotypal and delusional disorders. Which are in treatment for at least six months. For which pharmacotherapy was prescribed; Those who accepted participate in the study by signing a Statement of Informed Consent.
Exclusion criteria
Exclusion criteria: Patients who are in crisis. Patients who have psychiatric symptom associated with a diagnosis inconclusive or not yet elucidated. Patients who have evidence or diagnosis of neurological or cognitive damage.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adherence to treatment and identification of drug influences. Haynes-Sackett test: consists in this question: "Most people have trouble taking pills, do you have some difficulty to take yours?" It is requested the average number of missed pills during a period of time (for example, in the last fortnight or last month). Good adherence can be characterized when the values are between 80% and 100%. Morinsky-Green test: for this method, patients that have good adherence are those who respond adequately to these four questions: 1) "do you ever forget to take your medication?" 2) "do you take the drugs at the indicated time? "3)" when you are well, do you stop taking your medications? "4)" if you ever feel bad, do you stop taking your medications?". For drug influences evaluation is used the Rating of Medication Influences (ROMI).;Knowledgement level about the treatment/medication use. The level of user awareness about the treatment or use of drugs will be set according to the percentage of individuals who report correctly the indication, dosage and method of using the drug ("when and how to use your medication") (WHO, 1993). Later, it will be used the formula: %CUM = X/Y x 100. Where: %CUM: percentage of knowledge about the medication use, Y: number of patients who respond correctly "when and how to use their medication" and X: total number of interviewed patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug-related problems. Drug-related problems is defined as negative clinical outcomes, derived from pharmacological treatment that has produced a number of causes as a consequence, does not reach the desired therapeutic goal or the appearance of undesirable effects. | — |
Countries
Brazil
Contacts
Public ContactJuliana;Wellington Rabelo;da Silva
Universidade Federal de Sergipe;Universidade Federal de Sergipe
Outcome results
None listed